作者
Laura L Dugan, Young-Hyun You, Sameh S Ali, Maggie Diamond-Stanic, Satoshi Miyamoto, Anne-Emilie DeCleves, Aleksander Andreyev, Tammy Quach, San Ly, Grigory Shekhtman, William Nguyen, Andre Chepetan, Thuy P Le, Lin Wang, Ming Xu, Kacie P Paik, Agnes Fogo, Benoit Viollet, Anne Murphy, Frank Brosius, Robert K Naviaux, Kumar Sharma
发表日期
2013/10/25
期刊
The Journal of clinical investigation
卷号
123
期号
11
出版商
American Society for Clinical Investigation
简介
Diabetic microvascular complications have been considered to be mediated by a glucose-driven increase in mitochondrial superoxide anion production. Here, we report that superoxide production was reduced in the kidneys of a steptozotocin-induced mouse model of type 1 diabetes, as assessed by in vivo real-time transcutaneous fluorescence, confocal microscopy, and electron paramagnetic resonance analysis. Reduction of mitochondrial biogenesis and phosphorylation of pyruvate dehydrogenase (PDH) were observed in kidneys from diabetic mice. These observations were consistent with an overall reduction of mitochondrial glucose oxidation. Activity of AMPK, the major energy-sensing enzyme, was reduced in kidneys from both diabetic mice and humans. Mitochondrial biogenesis, PDH activity, and mitochondrial complex activity were rescued by treatment with the AMPK activator 5-aminoimidazole-4 …
引用总数
201420152016201720182019202020212022202320242343545247415961313517
学术搜索中的文章